Researchers uncovered how loss of NF1 drives ER+ breast cancer to metastasize to the bone
August 24, 2026
August 24, 2026
HOUSTON, Texas, Aug. 24 -- The Baylor College of Medicine posted the following news:
* * *
Researchers uncovered how loss of NF1 drives ER+ breast cancer to metastasize to the bone
*
A Baylor College of Medicine-led team has uncovered how loss of tumor suppressor neurofibromin (NF1) in estrogen receptor-positive (ER+) breast cancer cells drives the cells' preference to metastasize to the bone.
The findings, published in Cancer . . .
* * *
Researchers uncovered how loss of NF1 drives ER+ breast cancer to metastasize to the bone
*
A Baylor College of Medicine-led team has uncovered how loss of tumor suppressor neurofibromin (NF1) in estrogen receptor-positive (ER+) breast cancer cells drives the cells' preference to metastasize to the bone.
The findings, published in Cancer . . .